Atıf Formatları
Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. F. TABAK Et Al. , "Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review," VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , no.2, pp.43-51, 2023

TABAK, Ö. F. Et Al. 2023. Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , no.2 , 43-51.

TABAK, Ö. F., YAPALI, S., Celen, M. K., & GÜNER, H. R., (2023). Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , no.2, 43-51.

TABAK, ÖMER Et Al. "Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review," VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , no.2, 43-51, 2023

TABAK, ÖMER F. Et Al. "Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , no.2, pp.43-51, 2023

TABAK, Ö. F. Et Al. (2023) . "Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , no.2, pp.43-51.

@article{article, author={ÖMER FEHMİ TABAK Et Al. }, title={Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review}, journal={VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL}, year=2023, pages={43-51} }